加巴喷丁与安慰剂治疗椎间盘突出所致急性腰骶神经根性疼痛:GRADE随机对照双盲优效性试验的研究方案
GRADE试验是一项在法国6个中心开展的前瞻性、随机、多中心、双盲、优效性III期试验,比较3天加巴喷丁方案与安慰剂治疗症状持续不足3个月的椎间盘突出所致急性腰骶神经根性疼痛,主要结局为第1天至第4天神经根性疼痛视觉模拟量表的变化,主要采用意向性治疗分析。
要点
- 椎间盘突出所致急性腰骶神经根性疼痛常见且剧烈,标准保守治疗未针对可能的急性神经病理性疼痛。
- GRADE试验将加巴喷丁3天方案与安慰剂按1:1随机比较,纳入症状持续不足3个月的患者。
- 主要结局为第1天至第4天神经根性疼痛视觉模拟量表的变化,主要采用意向性治疗分析。
核心结论
- 作者假设短期加巴喷丁疗程可改善椎间盘突出所致急性腰骶神经根性疼痛的疼痛管理。
- 研究结果将为急性腰骶神经根性疼痛的疼痛管理未来推荐提供信息。
研究设计与样本
- GRADE研究是一项前瞻性、随机、多中心、双盲、优效性III期试验,比较3天加巴喷丁方案与安慰剂,按1:1比例随机。
- 纳入标准为椎间盘突出所致急性腰骶神经根性疼痛且症状持续不足3个月的患者,在法国6个中心纳入。
- 主要结局为第1天至第4天神经根性疼痛视觉模拟量表的变化,主要采用意向性治疗分析。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute lumbosacral radiculopathy from disc herniation is common and particularly painful. The challenge is to provide sufficient relief to patients until the natural regression of the herniated disc allows them to heal, primarily using conservative medical treatment combining physical measures, antinociceptive analgesics, and systemic anti-inflammatory drugs. Nerve root impingement is likely to cause acute neuropathic pain, which is not currently managed by standard conservative medical treatment. We hypothesised that a short course of gabapentin could improve pain management in acute lumbosacral radiculopathy from disc herniation. METHODS: The GRADE (Gabapentin versus placebo for the treatment of acute lumbosacral RAdicular pain caused by Disc hErniation) study is a prospective, randomized, multicenter, double-blind, superiority phase III trial comparing a 3-day regimen of gabapentin to placebo with a 1:1 ratio. Patients with acute lumbosacral radiculopathy from disc herniation with symptoms of less than 3 months are included in 6 centres in France. The primary outcome is the change in the radicular pain Visual Analogue Scale between Day 1 and Day 4. Intention-to-treat analysis will be applied primarily. DISCUSSION: Ethics approval was obtained from the committee for the protection of persons (Comité de Protection des Personnes Sud-Ouest et Outre-Mer 1: 1-21-023 ID 11548). The findings from this study, whether positive or negative, will be published in peer-reviewed journals and will be presented at national and international conferences. The results will inform future recommendations on the pain management in acute lomboradicular pain. TRIAL REGISTRATION NUMBER: EudraCT: 2020-002849-42 Clinicaltrials NCT04865042. 19 April 2021.
引用
- Ducoulombier V, Coquerelle P, Candelier JB, et al. Gabapentin versus placebo for the treatment of acute lumbosacral radicular pain caused by disc herniation: study protocol of the GRADE randomized controlled double-blind superiority trial. Trials. 2025. PMID: 41137125. doi:10.1186/s13063-025-09139-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。